 | Up a level |
Number of items: 1.
Gadea, O. Saavedra Santa, Greil, R., De Jonge, M. J. A., Tan, D., Jerusalem, G., Damian, S., Grell, P., Wainberg, Z., Wolf, J., Joerger, M., Carlino, M. S., Kasper, S., Yap, T. A., Otero, J., Yang, X., Nesbitt, V., Kim, J., Lee, L. Ho, Choudhury, S. and Leal, T. A. (2021). Phase (Ph) II study of taminadenant (NIR178) + spartalizumab (PDR001) in patients (pts) with microsatellite stable (MSS) colorectal cancer (CRC). Ann. Oncol., 32. S. S552 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041